GE confirms imminent job cuts
This article was originally published in Clinica
After previously declining to comment on internal business plans aimed at boosting its bottom line, GE Healthcare has confirmed that it is set to make job cuts. A spokesperson for the firm told The Business Journal of Milwaukee that GE was to make an unspecified number of cuts in order to “strengthen the company to better perform in the current economic environment and position it for profitable long term growth”. Scrutiny had been placed on the Chalfont St Giles, UK-based firm since its poor Q3 results in October (see Clinica No 1326, p 21). The brunt of the cuts may be taken by the firm’s underperforming imaging unit – last month, GE’s medtech rival Philips announced that it was to axe 1,600 positions, with a high proportion of the cuts being in the imaging sector (see Clinica No 1329, p 3). GE employs around 46,000 people in around 100 countries.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals